Propafenone facilitates mitochondrial-associated ferroptosis and synergizes with immunotherapy in melanoma
Background Despite the successful application of immunotherapy, both innate and acquired resistance are typical in melanoma. Ferroptosis induction appears to be a potential strategy to enhance the effectiveness of immunotherapy. However, the relationship between the status of ferroptosis and the eff...
Saved in:
| Main Authors: | Hong Liu, Qian Zhou, Yi He, Xiang Chen, Hui Su, Yu Meng, Yating Dian, Lei Yao, Yuming Sun, Daishi Li, Yixiao Xiong, Furong Zeng, Xiaowei Liang, Guangtong Deng |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2024-11-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/12/11/e009805.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PGAM1 Inhibition Promotes HCC Ferroptosis and Synergizes with Anti‐PD‐1 Immunotherapy
by: Yimin Zheng, et al.
Published: (2023-10-01) -
Immune checkpoint inhibitors in cancer patients with autoimmune disease: Safety and efficacy
by: Jiayuan Le, et al.
Published: (2025-12-01) -
Propafenone-Induced Cholestatic Liver Injury: When Diagnosis Does Not Skip a Beat
by: Ana Isabel Ferreira, et al.
Published: (2024-10-01) -
iDICss robustly predicts melanoma immunotherapy response by synergizing genomic and transcriptomic knowledge via independent component analysis
by: Jiayue Qiu, et al.
Published: (2025-01-01) -
Regulation of Oxygen in the Tumor Microenvironment Synergizes with Immunotherapy to Suppress Tumor Progression
by: Shoucheng Wang, et al.
Published: (2024-11-01)